Get the Stockscreener App
4.50
7.02%
-0.34
After Hours:
4.72
0.22
+4.89%
Adverum Biotechnologies Inc Stock (ADVM) Forecast
The Adverum Biotechnologies Inc (ADVM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.02, representing a +211.66% increase from the current price of $4.50. The highest analyst price target is $17.11, and the lowest is $10.94.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ADVM Price Target
Average 20.75
(+361.07% Upside)
Is Adverum Biotechnologies Inc (ADVM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.62 | Neutral |
| STOCH(9,6) | 55.90 | Neutral |
| STOCHRSI(14) | 67.01 | Neutral |
| MACD(12,26) | 0.0464 | Buy |
| ADX(14) | 19.65 | Neutral |
| William %R | -39.51 | Neutral |
| CCI(14) | 66.47 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.493
Buy
|
4.4845
Buy
|
| MA20 |
4.317
Buy
|
4.4124
Buy
|
| MA50 |
4.4022
Buy
|
4.6226
Sell
|
| MA100 |
5.5201
Sell
|
5.2951
Sell
|
| MA200 |
6.4153
Sell
|
6.7568
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ADVM could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ADVM, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 51.62 indicates that ADVM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.9 indicates that ADVM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 67.01 indicates that ADVM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.65 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 66.47 indicates that ADVM is still overbought but not to an extreme extent.
Long-term ADVM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Adverum Biotechnologies Inc financial reports and earnings history, Adverum Biotechnologies Inc (ADVM) stock could reach $17.99 by 2030, $14.46 by 2040 and $22.08 by 2050. See the projected annual prices until 2050 of the Adverum Biotechnologies Inc stock below:
- Adverum Biotechnologies Inc (ADVM) is expected to reach an average price of $10.22 in 2035, with a high prediction of $10.47 and a low estimate of $10.14. This indicates an $127.05% rise from the last recorded price of $4.50.
- Adverum Biotechnologies Inc (ADVM) stock is projected to chart a bullish course in 2040, with an average price target of $14.24, representing an $216.42% surge from its current level. The forecast ranges from a conservative $14.09 to a sky-high $14.46.
- Our analysts predict Adverum Biotechnologies Inc (ADVM) to jump 304.47% by 2045, soaring from $18.08 to an average price of $18.20, potentially reaching $18.38. While $18.08 is the low estimate, the potential upside is significant.
- Adverum Biotechnologies Inc (ADVM) stock is expected to climb by 2050, reaching an average of $22.08, a $390.66% jump from its current level. However, a wide range of estimates exists, with high and low targets of $22.08 and $21.82, respectively, highlighting the market's uncertainty.
Adverum Biotechnologies Inc Stock (ADVM) Year by Year Forecast
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2025
Adverum Biotechnologies Inc Stock (ADVM) is expected to reach an average price of $20.75 in 2025, with a high prediction of $30.56 and a low estimate of $10.94. This indicates an +361.07% rise from the last recorded price of $4.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $13.11 | $10.94 | $17.11 | +191.35% |
| May, 2025 | $17.45 | $11.79 | $17.95 | +287.72% |
| June, 2025 | $21.65 | $14.69 | $27.33 | +381.09% |
| July, 2025 | $28.12 | $20.11 | $28.72 | +524.80% |
| August, 2025 | $23.48 | $22.24 | $30.56 | +421.73% |
| September, 2025 | $22.08 | $20.14 | $24.34 | +390.66% |
| October, 2025 | $15.26 | $14.65 | $22.47 | +239.03% |
| November, 2025 | $13.97 | $13.77 | $16.97 | +210.40% |
| December, 2025 | $14.61 | $13.50 | $16.27 | +224.56% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2026
The predicted value for Adverum Biotechnologies Inc (ADVM) in 2026 is set at an average of $12.28. Estimates vary from a peak of $18.56 to a trough of $6.0036, indicating an +172.88% surge from the present price of $4.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $17.82 | $14.52 | $18.29 | +295.93% |
| February, 2026 | $16.07 | $15.32 | $18.43 | +257.08% |
| March, 2026 | $15.13 | $14.30 | $17.08 | +236.23% |
| April, 2026 | $16.64 | $15.08 | $18.56 | +269.71% |
| May, 2026 | $14.74 | $14.02 | $17.67 | +227.53% |
| June, 2026 | $12.91 | $12.81 | $14.99 | +186.90% |
| July, 2026 | $7.4575 | $7.3121 | $14.18 | +65.72% |
| August, 2026 | $7.5991 | $7.2083 | $7.6741 | +68.87% |
| September, 2026 | $7.4462 | $7.2162 | $7.75 | +65.47% |
| October, 2026 | $6.4078 | $6.1578 | $7.5716 | +42.40% |
| November, 2026 | $6.3795 | $6.0036 | $6.5132 | +41.77% |
| December, 2026 | $6.1465 | $6.0657 | $6.5199 | +36.59% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Adverum Biotechnologies Inc (ADVM) is $5.7424, with a high forecast of $6.5073 and a low forecast of $4.9774. This indicates an +27.61% increase from the last price of $4.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.9471 | $5.9181 | $6.5073 | +32.16% |
| February, 2027 | $6.0098 | $5.8936 | $6.379 | +33.55% |
| March, 2027 | $5.8168 | $5.7206 | $6.0752 | +29.26% |
| April, 2027 | $5.7185 | $5.6185 | $6.1031 | +27.08% |
| May, 2027 | $5.6101 | $5.5293 | $5.7701 | +24.67% |
| June, 2027 | $5.3472 | $5.3472 | $5.7055 | +18.83% |
| July, 2027 | $5.4488 | $5.338 | $5.6434 | +21.08% |
| August, 2027 | $5.3004 | $5.2554 | $5.5096 | +17.79% |
| September, 2027 | $5.0753 | $4.9774 | $5.3658 | +12.78% |
| October, 2027 | $5.2091 | $5.0683 | $5.3137 | +15.76% |
| November, 2027 | $5.7608 | $5.1945 | $5.7908 | +28.02% |
| December, 2027 | $5.7278 | $5.5224 | $6.0562 | +27.28% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2028
In 2028, Adverum Biotechnologies Inc (ADVM) is projected to reach an average price of $5.5412, with a high projection of $6.1691 and a low estimate of $4.9132. This indicates an +23.14% rise from the last price of $4.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.3894 | $5.3294 | $5.7632 | +19.77% |
| February, 2028 | $5.2511 | $5.1811 | $5.5103 | +16.69% |
| March, 2028 | $5.1931 | $5.1673 | $5.3765 | +15.40% |
| April, 2028 | $5.0604 | $4.9743 | $5.2882 | +12.45% |
| May, 2028 | $4.9468 | $4.9197 | $5.0752 | +9.93% |
| June, 2028 | $5.0784 | $4.9132 | $5.0939 | +12.85% |
| July, 2028 | $5.0486 | $5.0301 | $5.1401 | +12.19% |
| August, 2028 | $5.2371 | $5.0415 | $5.2861 | +16.38% |
| September, 2028 | $5.1498 | $5.1498 | $5.3125 | +14.44% |
| October, 2028 | $5.298 | $5.1552 | $5.4996 | +17.73% |
| November, 2028 | $5.7275 | $5.2442 | $5.7575 | +27.28% |
| December, 2028 | $6.1291 | $5.6329 | $6.1691 | +36.20% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2029
The 2029 price forecast for Adverum Biotechnologies Inc Stock (ADVM) is $13.93 on average, with a high prediction of $22.43 and a low estimate of $5.4414. This represents an +209.65% increase from the previous price of $4.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.7461 | $6.0445 | $6.8953 | +49.91% |
| February, 2029 | $6.1878 | $6.0978 | $6.8265 | +37.51% |
| March, 2029 | $6.1694 | $6.1094 | $6.454 | +37.10% |
| April, 2029 | $5.6097 | $5.5662 | $6.3802 | +24.66% |
| May, 2029 | $5.5946 | $5.4897 | $5.8081 | +24.32% |
| June, 2029 | $5.5072 | $5.461 | $5.6091 | +22.38% |
| July, 2029 | $5.4542 | $5.4414 | $5.7251 | +21.20% |
| August, 2029 | $5.7784 | $5.4599 | $5.8484 | +28.41% |
| September, 2029 | $6.7501 | $5.7638 | $7.7092 | +50.00% |
| October, 2029 | $20.84 | $6.1771 | $22.43 | +363.05% |
| November, 2029 | $16.14 | $15.72 | $21.22 | +258.64% |
| December, 2029 | $13.02 | $12.56 | $16.67 | +189.33% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2030
Adverum Biotechnologies Inc Stock (ADVM) is expected to reach an average price of $17.72 in 2030, with a high forecast of $23.76 and a low forecast of $11.68. This signifies an +293.74% surge from the last price of $4.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.36 | $12.71 | $17.99 | +285.87% |
| February, 2030 | $21.64 | $17.20 | $22.76 | +380.94% |
| March, 2030 | $17.87 | $17.68 | $22.95 | +297.01% |
| April, 2030 | $16.90 | $16.84 | $20.50 | +275.64% |
| May, 2030 | $12.18 | $11.68 | $19.56 | +170.73% |
| June, 2030 | $14.10 | $11.68 | $14.29 | +213.28% |
| July, 2030 | $16.65 | $13.33 | $16.76 | +269.90% |
| August, 2030 | $17.57 | $16.63 | $18.51 | +290.53% |
| September, 2030 | $17.90 | $17.15 | $19.31 | +297.82% |
| October, 2030 | $22.74 | $16.69 | $22.77 | +405.25% |
| November, 2030 | $16.44 | $14.52 | $23.76 | +265.32% |
| December, 2030 | $15.87 | $14.43 | $19.21 | +252.72% |
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):